KM
Kandepi Malleswari Naga
About Kandepi Malleswari Naga
Data last updated:
Kandepi Malleswari Naga is a Whole-Time Director at Athulitha Laboratories Private Limited (since 2011) and Director at Gnanis Pharma Private Limited (since 2020). The companies operate in Pharma and Chemicals. The largest current company by reported revenue is Athulitha Laboratories Private Limited at ₹22.56 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 19 Oct 2011 | 2011 | ₹22.56 Cr (FY 2024) | Active | |
| Director | 12 Sep 2020 | 2020 | Active |
Board colleagues of Kandepi Malleswari Naga
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gnaneswar Kandepi | 08861606 | Athulitha Laboratories Private Limited , Gnanis Pharma Private Limited | Director |
| Harshita Agrawal | Athulitha Laboratories Private Limited | Company Secretary | |
| Srinivasa Rao Kandepi | 03603438 | Athulitha Laboratories Private Limited , Gnanis Pharma Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kandepi Malleswari Naga
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kandepi Malleswari Naga
Kandepi Malleswari Naga currently holds 2 directorships: Athulitha Laboratories Private Limited (Whole-Time Director, since 19 Oct 2011, revenue ₹22.56 Cr (FY 2024)); Gnanis Pharma Private Limited (Director, since 12 Sep 2020).
Kandepi Malleswari Naga was first appointed on 19 Oct 2011 as Whole-Time Director at Athulitha Laboratories Private Limited. The most recent appointment on record is 12 Sep 2020 at Gnanis Pharma Private Limited.
The current boards of Kandepi Malleswari Naga's companies include Gnaneswar Kandepi (Athulitha Laboratories Private Limited), Harshita Agrawal (Athulitha Laboratories Private Limited), Srinivasa Rao Kandepi (Athulitha Laboratories Private Limited).